News & Events
August 7, 2019
Funded by FDA, C-Path and NORD to Launch Rare Disease Data and Analytics Platform
TUCSON, Ariz. and WASHINGTON, August 7, 2019 — The Critical Path Institute (C-Path) and the National Organization for Rare Disorders® (NORD) will host a meeting on Tuesday, September 17 in Bethesda, MD to formally launch development of a new rare disease data and analytics platform. Funded by a cooperative agreement through the Food and Drug Administration, [Critical Path Public-Private Partnerships Grant Number U18 FD005320 from the US Food and Drug Administration] the goal of the platform is to accelerate the movement of therapies from bench to bedside for rare diseases. The platform will provide the infrastructure for a sustainable, cooperative scientific approach to clinical trial readiness in rare diseases by addressing vast knowledge gaps about the natural course of disease, the clinical evaluation of new treatments, and patients’ perspective on disease and treatment.
January 17, 2019
Critical Path Institute Celebrates Expanded Operations with Opening of European HeadquartersC-Path in the EU will work to accelerate the development of new therapies through innovative methodologies for endorsement by regulators of pharmaceutical products TUCSON, Ariz., January 17, 2019 — Critical Path Institute (C-Path) is excited to announce the launch of Critical Path Institute, Ltd. (C-Path, Ltd.) in Ireland, a fully-owned subsidiary that will enable C-Path to......
October 31, 2018
C-Path, CHDI and CDISC Announce Therapeutic Area User Guide for Huntington’s DiseaseTUCSON, Ariz., NEW YORK and AUSTIN, Texas, November 1, 2018 — The Huntington’s Disease Regulatory Science Consortium (HD-RSC), launched in March 2018 by the Critical Path Institute (C-Path) and CHDI Foundation, today, along with the Clinical Data Interchange Standards Consortium (CDISC), announce the open availability of a newly developed Huntington’s Disease Therapeutic Area User Guide......
September 12, 2018
UA Colleges of Law and Pharmacy, Critical Path Institute, Launch Graduate Certificate Program in Regulatory ScienceDesigned for graduate students and working professionals, the certificate program provides specialized training in navigating the path from research to bringing medical products to market. TUCSON, Ariz., September 25, 2018 — The University of Arizona and the Critical Path Institute have launched a new online graduate certificate program designed to equip students and working......
June 13, 2017
C-Path and CDISC Announce Public Review Period for Duchenne Therapeutic Area StandardJune 13, 2017 TUCSON, Ariz., and AUSTIN, Texas – June 13, 2017 – The Clinical Data Interchange Standards Consortium (CDISC) and Critical Path Institute (C-Path) announce the availability of a Duchenne muscular dystrophy therapeutic area user guide (TAUG-DMD v1.0) for public review. The review period for the TAUG-DMD v1.0 began on May 8, 2017, and runs through July 6,......